Toll Free: 1-888-928-9744

Curetis N.V. (CURE) - Product Pipeline Analysis, 2016 Update

Published: Jun 22, 2016 | Pages: 46 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Curetis N.V. (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers products such as unyvero L4 lyastors, unyvero C8 cockpits, unyvero A50 analyzer and unyvero application cartridges. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia or implant and tissue infections. Curetis offers research, and commercial product development services. The company caters to biotechnology, contract research, medical, healthcare and pharmaceutical industries. It sells its products through a network of distributors in Germany and abroad. Curetis is headquartered in Holzgerlingen, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Curetis N.V.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 Curetis N.V. Company Snapshot 7 Curetis N.V. Company Overview 7 Curetis N.V. Pipeline Products and Clinical Trials Overview 8 Curetis N.V. - Pipeline Analysis Overview 10 Key Facts 10 Curetis N.V. - Major Products and Services 11 Curetis N.V. Pipeline Products by Development Stage 12 Curetis N.V. Clinical Trials by Trial Status 14 Curetis N.V. Pipeline Products Overview 16 Antibiotic Resistance Marker Cartridge 16 Antibiotic Resistance Marker Cartridge Product Overview 16 Immuno-Compromised Patient Cartridge 17 Immuno-Compromised Patient Cartridge Product Overview 17 Second-Generation ITI Application Cartridge 18 Second-Generation ITI Application Cartridge Product Overview 18 Unyvero Analyzer 19 Unyvero Analyzer Product Overview 19 Unyvero Analyzer Clinical Trial 20 Unyvero BCU Cartridge 21 Unyvero BCU Cartridge Product Overview 21 Unyvero Cartridge - CNS Infections 22 Unyvero Cartridge - CNS Infections Product Overview 22 Unyvero Cartridge - Gastrointestinal Tract Infections 23 Unyvero Cartridge - Gastrointestinal Tract Infections Product Overview 23 Unyvero Cartridge - Intra-Abdominal Infections 24 Unyvero Cartridge - Intra-Abdominal Infections Product Overview 24 Unyvero Cartridge - Pediatric Infections 25 Unyvero Cartridge - Pediatric Infections Product Overview 25 Unyvero i60 Cartridge 26 Unyvero i60 Cartridge Product Overview 26 Unyvero Implant & Tissue Infections Cartridge 27 Unyvero Implant & Tissue Infections Cartridge Product Overview 27 Unyvero P50 LRT 28 Unyvero P50 LRT Product Overview 28 Unyvero P50 LRT Clinical Trial 29 Unyvero P55 LRT Pneumonia 30 Unyvero P55 LRT Pneumonia Product Overview 30 Unyvero P55 LRT Pneumonia Clinical Trial 31 Unyvero Sepsis Host Response Test 32 Unyvero Sepsis Host Response Test Product Overview 32 Unyvero Tuberculosis Cartridge 33 Unyvero Tuberculosis Cartridge Product Overview 33 Curetis N.V. - Key Competitors 34 Curetis N.V. - Key Employees 35 Curetis N.V. - Locations And Subsidiaries 36 Head Office 36 Recent Developments 37 Curetis N.V., Recent Developments 37 Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement 37 May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update 37 Apr 12, 2016: Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance 38 Jan 11, 2016: Curetis Establishes Medical Advisory Board with Internationally Renowned Experts 40 Oct 29, 2015: Curetis Announces New Supervisory Board of Curetis N.V. 40 Sep 25, 2015: Curetis Enters Into Distribution Agreement to Expand Commercial Activities Into Greater China 41 Jul 08, 2015: Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections 42 May 11, 2015: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer 43 Apr 20, 2015: Curetis Expands Commercial Organization 43 Apr 16, 2015: Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015 44 Appendix 46 Methodology 46 About GlobalData 46 Contact Us 46 Disclaimer 46
List of Tables
Curetis N.V. Pipeline Products and Clinical Trials Overview 8 Curetis N.V. Pipeline Products by Equipment Type 8 Curetis N.V. Pipeline Products by Indication 9 Curetis N.V. Clinical Trials by Trial Status 9 Curetis N.V., Key Facts 10 Curetis N.V., Major Products and Services 11 Curetis N.V. Number of Pipeline Products by Development Stage 12 Curetis N.V. Pipeline Products Summary by Development Stage 13 Curetis N.V. Clinical Trials by Trial Status 14 Curetis N.V. Clinical Trials Summary 15 Antibiotic Resistance Marker Cartridge - Product Status 16 Antibiotic Resistance Marker Cartridge - Product Description 16 Immuno-Compromised Patient Cartridge - Product Status 17 Immuno-Compromised Patient Cartridge - Product Description 17 Second-Generation ITI Application Cartridge - Product Status 18 Second-Generation ITI Application Cartridge - Product Description 18 Unyvero Analyzer - Product Status 19 Unyvero Analyzer - Product Description 19 Unyvero Analyzer - Detection of Microorganisms and Antibiotic Resistance Genes in Lower Respiratory Tract (LRT) Samples Using the Curetis Unyvero LRT55 Application 20 Unyvero BCU Cartridge - Product Status 21 Unyvero BCU Cartridge - Product Description 21 Unyvero Cartridge - CNS Infections - Product Status 22 Unyvero Cartridge - CNS Infections - Product Description 22 Unyvero Cartridge - Gastrointestinal Tract Infections - Product Status 23 Unyvero Cartridge - Gastrointestinal Tract Infections - Product Description 23 Unyvero Cartridge - Intra-Abdominal Infections - Product Status 24 Unyvero Cartridge - Intra-Abdominal Infections - Product Description 24 Unyvero Cartridge - Pediatric Infections - Product Status 25 Unyvero Cartridge - Pediatric Infections - Product Description 25 Unyvero i60 Cartridge - Product Status 26 Unyvero i60 Cartridge - Product Description 26 Unyvero Implant & Tissue Infections Cartridge - Product Status 27 Unyvero Implant & Tissue Infections Cartridge - Product Description 27 Unyvero P50 LRT - Product Status 28 Unyvero P50 LRT - Product Description 28 Unyvero P50 LRT - Detection of Microorganisms and Antibiotic Resistance Genes in Lower Respiratory Tract (LRT) Samples Using the Curetis Unyvero LRT55 Application 29 Unyvero P55 LRT Pneumonia - Product Status 30 Unyvero P55 LRT Pneumonia - Product Description 30 Unyvero P55 LRT Pneumonia - Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application 31 Unyvero Sepsis Host Response Test - Product Status 32 Unyvero Sepsis Host Response Test - Product Description 32 Unyvero Tuberculosis Cartridge - Product Status 33 Unyvero Tuberculosis Cartridge - Product Description 33 Curetis N.V., Key Employees 35


List of Figures
Curetis N.V. Pipeline Products by Equipment Type 9 Curetis N.V. Pipeline Products by Development Stage 12 Curetis N.V. Clinical Trials by Trial Status 14

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify